Personalised medicine provides optimal treatment

vrijdag 7 november 2014 12:00

In personalised medicine, patients are treated with medicinal products according to their individual characteristics, such as genetic background, instead of a traditional one-size-fits-all approach. Genetic screening of patients for effective and safe treatment with medicinal products is performed using in vitro diagnostic devices (IVDs), including genetic tests. Therefore, in personalised medicine, medicinal products and IVDs are linked. However, different regulatory frameworks exist for these two components of personalised medicine. The current RIVM report states that in order to adequately control the risks of personalised medicine, the legislation of medicinal products and that of IVDs should be linked. Also, RIVM research reveals that the training of healthcare professionals in the use of personalised medicine techniques needs to be improved.